Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000019617-25-000434·ALTERITY THERAPEUTICS LTD
Schedule 13G ownership disclosure
ALTERITY THERAPEUTICS LTD
American Depositary Shares, each representing 600 Ordinary Shares · CUSIP: Q02676106
Event date: 2025-04-30
- Filing-level shares
- 366,034,937
- Percent of class
- 4.0%
- JPMORGAN CHASE & CO.
Shares: 366,034,937 · Class: 4.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000019617-25-000434
- Form type
- SCHEDULE 13G/A
- Filer
- ALTERITY THERAPEUTICS LTD
- CIK
- CIK 1131343
- Filed
- May 05, 2025
- Reporting period
- Apr 30, 2025
- Description
- Schedule 13G beneficial ownership